(Q46078455)

19 December 2017

title

Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations (English)

1 reference

19 December 2017

1 reference

Matthew Cossack

1

1 reference

19 December 2017

Cameron Ghaffary

2

1 reference

19 December 2017

Patrice Watson

3

1 reference

19 December 2017

Carrie Snyder

4

1 reference

19 December 2017

Henry Lynch

5

1 reference

19 December 2017

publication date

25 July 2013

1 reference

19 December 2017

Journal of Genetic Counseling

published in

1 reference

19 December 2017

volume

23

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

187-191

1 reference

19 December 2017

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Mendelian inheritance of familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Unravelling the genetics of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Smoking and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Germline BRCA1 mutations increase prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Risk factors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Statin drugs and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Coffee consumption and prostate cancer risk: further evidence for inverse relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Inflammation and prostate cancer: a future target for prevention and therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Cancer worry among Norwegian male BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-013-9629-8

Comparison of next-of-kin with self-respondents regarding questions on cigarette, coffee, and alcohol consumption

21 January 2018

1 reference

12 December 2020

Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth

1 reference

12 December 2020

Cancer statistics, 2012

1 reference

12 December 2020

Case-control study of lifetime total physical activity and prostate cancer risk

1 reference

12 December 2020

10.1007/S10897-013-9629-8

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017